Article Information
History
- September 26, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Oliver Pearse1,2,#,
- Allan Zuza2,
- Edith Tewesa3,
- Patricia Siyabuh3,
- Alice J Fraser4,
- Jennifer Cornick2,5,
- Kondwani Kawaza2,6,
- Patrick Musicha2,4,7,
- Nicholas R Thomson7,8,
- Nicholas A Feasey1,2,9,* and
- Eva Heinz1,4,10,#,*
- 1Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
- 2Malawi-Liverpool-Wellcome Programme, Kamuzu University of Health Sciences, Blantyre, Malawi
- 3Queen Elizabeth Central Hospital, Blantyre, Malawi
- 4Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK
- 5University of Liverpool, Institute of Infection, Veterinary and Ecological Sciences, Liverpool, UK
- 6Kamuzu University of Health Sciences, Malawi
- 7Wellcome Sanger Institute, Parasites and Microbes Program, Hinxton, UK
- 8London School of Tropical Medicine and Hygiene, Department of Pathogen Molecular Biology, London, UK
- 9The School of Medicine, University of St. Andrews, St. Andrews, UK
- 10University of Strathclyde, Strathclyde Institute for Pharmacy and Biomedical Sciences, Glasgow, UK
- ↵#Corresponding author Email: oliver.pearse{at}lstmed.ac.uk; eva.heinz{at}strath.ac.uk
↵* Equally contributing
Posted September 26, 2024.
High diversity of Escherichia coli causing invasive disease in neonates in Malawi poses challenges for O-antigen based vaccine approach
